TY  - JOUR
AU  - Macías, J
AU  - Monge, P
AU  - Mancebo, M
AU  - Merchante, N
AU  - Neukam, K
AU  - Real, L M
AU  - Pineda, J A
PY  - 2016
DO  - 10.1111/hiv.12471
UR  - http://hdl.handle.net/10668/10632
T2  - HIV medicine
AB  - The aim of the study was to analyse the frequency and degree of potential drug-drug interactions (DDIs) between direct-acting antivirals (DAAs) and concomitant medication used by HIV/hepatitis C virus (HCV)-coinfected patients, including...
LA  - en
KW  - antiretroviral therapy
KW  - common medications
KW  - daclatasvir
KW  - direct acting antiviral agents against HCV
KW  - drug-drug interactions
KW  - ledipasvir
KW  - paritaprevir/r/ombitasvir ± ombitasvir
KW  - simeprevir
KW  - sofosbuvir
KW  - Antiviral Agents
KW  - Coinfection
KW  - Cross-Sectional Studies
KW  - Drug Interactions
KW  - Female
KW  - HIV Infections
KW  - Hepatitis C, Chronic
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Spain
KW  - Tertiary Care Centers
TI  - High frequency of potential interactions between direct-acting antivirals and concomitant therapy in HIV/hepatitis C virus-coinfected patients in clinical practice.
TY  - research article
VL  - 18
ER  -